Bull Harbor Capital LLC Invests $637,000 in Agilent Technologies, Inc. $A

Bull Harbor Capital LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,592 shares of the medical research company’s stock, valued at approximately $637,000.

Several other hedge funds and other institutional investors have also made changes to their positions in A. Brighton Jones LLC boosted its stake in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the period. Jones Financial Companies Lllp lifted its holdings in shares of Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares during the period. Geneos Wealth Management Inc. grew its position in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares in the last quarter. Acadian Asset Management LLC grew its position in shares of Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after buying an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC purchased a new position in shares of Agilent Technologies during the second quarter valued at $273,000.

Agilent Technologies Stock Performance

A opened at $138.72 on Friday. The firm has a market capitalization of $39.18 billion, a PE ratio of 27.86, a P/E/G ratio of 2.49 and a beta of 1.25. The firm has a 50 day moving average of $131.89 and a two-hundred day moving average of $125.21. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period last year, the firm earned $1.31 EPS. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 6.01 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is 20.48%.

Analyst Ratings Changes

A number of research firms recently weighed in on A. Robert W. Baird upped their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price target for the company. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. TD Cowen lifted their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Finally, HSBC reduced their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $159.35.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.